How does Clorox (CLX) make money?

Clorox (CLX) generates revenue primarily from Health and Wellness, which accounted for 38.1% of total revenue in TTM through Q1 2026. The company reported $6.76B in revenue and converted 11.2% of it into net profit, equivalent to roughly $756.00M in net income — what's left after the cost of revenue, operating expenses, interest, and income taxes.

What is the gross profit margin of Clorox (CLX)?

Clorox (CLX) reported a gross profit margin of 43.8% in TTM through Q1 2026, equivalent to $2.96B in gross profit on $6.76B in revenue. Gross margin measures how much of each dollar of revenue remains after the direct cost of producing or delivering the product — a higher figure typically signals pricing power, scale, or a less capital-intensive business model.

What is the operating profit margin of Clorox (CLX)?

Clorox (CLX) reported an operating profit margin of 15.7% in TTM through Q1 2026, equivalent to $1.06B in operating income. Operating margin captures profitability after research & development, sales & marketing, and general & administrative expenses — but before interest, taxes, and one-off items — and is the cleanest single read on the underlying business's efficiency.

What is the net profit margin of Clorox (CLX)?

Clorox (CLX) reported a net profit margin of 11.2% in TTM through Q1 2026, equivalent to $756.00M in net income. Net margin is the bottom-line share of revenue that survives every expense — operating costs, interest, and income taxes — and is the figure that flows directly into earnings per share.

Is Clorox (CLX) profitable?

Yes. Clorox (CLX) reported $756.00M in net income for TTM through Q1 2026, with a net profit margin of 11.2%. The company earned more from its operations than it paid out in costs, interest, and income taxes, leaving positive earnings on the bottom line.

How much does Clorox (CLX) invest in research and development?

Clorox (CLX) invested $116.00M in research and development during TTM through Q1 2026, roughly 1.7% of total revenue. R&D spending funds the company's future product pipeline and is expensed in full on the income statement rather than capitalised, which makes the operating margin sensitive to how aggressively management chooses to reinvest in innovation.

How much does Clorox (CLX) spend on capital expenditures?

Clorox (CLX) spent $196.00M on capital expenditures (CapEx) during TTM through Q1 2026, roughly 2.9% of total revenue. CapEx represents long-lived investment in property, equipment, data centres, and other physical infrastructure, and is subtracted from operating cash flow to arrive at free cash flow.

How much free cash flow does Clorox (CLX) generate?

Clorox (CLX) generated $380.00M in free cash flow during TTM through Q1 2026, a free-cash-flow margin of 5.6%. Free cash flow is the cash left after capital expenditures and represents the discretionary pool the company can use to pay dividends, repurchase shares, repay debt, or fund acquisitions without raising external capital.

What is the effective tax rate of Clorox (CLX)?

Clorox (CLX) had an effective tax rate of 22.1% in TTM through Q1 2026. The effective rate is the actual share of pre-tax income paid as income taxes and can differ materially from the statutory rate due to foreign earnings mix, tax credits (such as R&D), share-based compensation deductions, and one-off discrete items.

What are the main business segments of Clorox (CLX)?

Clorox (CLX) reports revenue across 4 reportable product segments, led by Health and Wellness at 38.1% of total revenue in TTM through Q1 2026. See the revenue-by-segment table on this page for the full breakdown and how each segment feeds into the income-statement waterfall above.

How Clorox Makes Money: 2026 Visual Revenue Map

Clorox (CLX) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported April 30, 2026).

Clorox discloses geographic revenue only in annual filings. to view the full breakdown.

Clorox (CLX) Revenue by Product Segment — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.

Revenue contribution by product segment for Clorox (CLX) in TTM through Q1 2026.
Segment	Revenue (USD)	% of total
Health and Wellness	$2.58B	38.1%
Household	$1.90B	28.1%
Lifestyle	$1.18B	17.5%
International	$1.10B	16.3%
Total	$6.76B	100%

Health and Wellness$2.58B
Household$1.90B
Lifestyle$1.18B
International$1.10B
Total$6.76B

Revenue Breakdown — TTM through Q1 2026

In TTM through Q1 2026, Clorox (CLX) reports revenue across 4 operating segments; the largest segment was Health and Wellness at 38.1%, followed by Household (28.1%) and Lifestyle (17.5%).

Frequently asked questions

Data & methodology

Clorox (CLX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation